PHIO vs. GLMD
PHIO (Phio Pharmaceuticals Corp.) and GLMD (Galmed Pharmaceuticals Ltd.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, PHIO returned -68.85%/yr vs -50.29%/yr for GLMD. At a 0.16 correlation, their price movements are largely independent.
Performance
PHIO vs. GLMD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PHIO achieves a 5.71% return, which is significantly higher than GLMD's -9.39% return. Over the past 10 years, PHIO has underperformed GLMD with an annualized return of -68.85%, while GLMD has yielded a comparatively higher -50.29% annualized return.
PHIO
- 1D
- -0.89%
- 1M
- -4.31%
- YTD
- 5.71%
- 6M
- -13.95%
- 1Y
- -46.89%
- 3Y*
- -66.70%
- 5Y*
- -65.39%
- 10Y*
- -68.85%
GLMD
- 1D
- -1.61%
- 1M
- 15.57%
- YTD
- -9.39%
- 6M
- -36.45%
- 1Y
- -54.05%
- 3Y*
- -77.13%
- 5Y*
- -74.35%
- 10Y*
- -50.29%
PHIO vs. GLMD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PHIO Phio Pharmaceuticals Corp. | 5.71% | -41.67% | -73.68% | -82.97% | -62.80% | -62.83% | -71.40% | -48.17% | -94.07% | -22.21% |
GLMD Galmed Pharmaceuticals Ltd. | -9.39% | -76.47% | -41.58% | -93.93% | -72.53% | -41.48% | -46.19% | -15.37% | -25.36% | 160.68% |
Correlation
The correlation between PHIO and GLMD is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Mar 14, 2014 | 0.16 |
Fundamentals
PHIO:
$12.90M
GLMD:
$4.48M
PHIO:
-$1.31
GLMD:
-$1.93
PHIO:
0.78
GLMD:
0.28
PHIO:
$0.00
GLMD:
$0.00
PHIO:
-$1.08M
GLMD:
$0.00
PHIO:
-$7.23M
GLMD:
-$8.49M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PHIO vs. GLMD — Risk / Return Rank
PHIO
GLMD
PHIO vs. GLMD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Phio Pharmaceuticals Corp. (PHIO) and Galmed Pharmaceuticals Ltd. (GLMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PHIO | GLMD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.55 | -0.63 | +0.08 |
Sortino ratioReturn per unit of downside risk | -0.52 | -0.69 | +0.17 |
Omega ratioGain probability vs. loss probability | 0.94 | 0.92 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | -0.66 | -0.68 | +0.02 |
Martin ratioReturn relative to average drawdown | -0.97 | -0.97 | 0.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PHIO | GLMD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.55 | -0.63 | +0.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.36 | -0.45 | +0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.46 | -0.37 | -0.09 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.25 | -0.38 | +0.13 |
Drawdowns
PHIO vs. GLMD - Drawdown Comparison
The maximum PHIO drawdown since its inception was -100.00%, roughly equal to the maximum GLMD drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for PHIO and GLMD.
Loading charts...
Drawdown Indicators
| PHIO | GLMD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -99.99% | -0.01% |
Max Drawdown (1Y)Largest decline over 1 year | -71.05% | -79.62% | +8.57% |
Max Drawdown (3Y)Largest decline over 3 years | -97.09% | -99.11% | +2.02% |
Max Drawdown (5Y)Largest decline over 5 years | -99.67% | -99.93% | +0.26% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -99.99% | -0.01% |
Current DrawdownCurrent decline from peak | -100.00% | -99.98% | -0.02% |
Average DrawdownAverage peak-to-trough decline | -91.34% | -74.35% | -16.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.30% | 55.49% | -7.19% |
Volatility
PHIO vs. GLMD - Volatility Comparison
The current volatility for Phio Pharmaceuticals Corp. (PHIO) is 11.25%, while Galmed Pharmaceuticals Ltd. (GLMD) has a volatility of 25.28%. This indicates that PHIO experiences smaller price fluctuations and is considered to be less risky than GLMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PHIO | GLMD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.25% | 25.28% | -14.03% |
Volatility (6M)Calculated over the trailing 6-month period | 64.55% | 62.60% | +1.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.29% | 86.30% | -0.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 183.79% | 166.29% | +17.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 150.17% | 137.58% | +12.59% |
Dividends
PHIO vs. GLMD - Dividend Comparison
Neither PHIO nor GLMD has paid dividends to shareholders.
Financials
PHIO vs. GLMD - Financials Comparison
This section allows you to compare key financial metrics between Phio Pharmaceuticals Corp. and Galmed Pharmaceuticals Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PHIO and GLMD have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GLMD has higher volatility (25.28%) compared to PHIO (11.25%). In terms of maximum drawdown, PHIO dropped -100.00% vs GLMD's -99.99%.
PHIO currently has the higher Sharpe Ratio (-0.55 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PHIO and GLMD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer